Sign in
4

Changes in Ownership

Korro Bio, Inc. Filed Acc 0000950170-23-065866

Director sold 968 shares at an average $41.97 ($40,632)

  • Director acquired 6,000 shares (grant or award)
  • Director acquired 5,600 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Lucchino David L. · Director

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2023-11-03 Exercise or conversion : show line 1 in the form +5,600 18,274 D
2023-11-03 Grant or award : show line 2 in the form +6,000 24,274 D
2023-11-10 Sale : show line 3 in the form −37 $37.92 $1,403 24,237 D
2023-11-10 Sale : show line 4 in the form −373 $39.59 $14,767 23,864 D
2023-11-10 Sale : show line 5 in the form −41 $41.94 $1,720 23,823 D
2023-11-10 Sale : show line 6 in the form −225 $43.17 $9,714 23,598 D
2023-11-10 Sale : show line 7 in the form −191 $44.01 $8,407 23,407 D
2023-11-10 Sale : show line 8 in the form −67 $45.53 $3,050 23,340 D
2023-11-10 Sale : show line 9 in the form −34 $46.23 $1,572 23,306 D
Open-market sales · 968 sh · avg $41.97 · $40,632

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-11-03 Exercise or conversion : show line 10 in the form Restricted Stock Units −5,600 0 D
Loading xslF345X05/ownership.xml…